[PDF][PDF] Advances and Challenges in Closed Loop Therapeutics: From Signal Selection to Optogenetic Techniques

F Pedro - Journal of Biomedical and Sustainable Healthcare …, 2024 - anapub.co.ke
The main objective of this paper is to develop closed-loop therapeutic systems by reviewing
various neurological disorders. We propose a system that incorporates a biosensor …

Targeted cancer therapy using compounds activated by light

P Dunkel, J Ilaš - Cancers, 2021 - mdpi.com
Simple Summary Cancer is among the leading causes of death, and cancer therapy suffers
from many drawbacks, the lack of selectivity being most noteworthy. In this review, we …

Photoswitchable inhibitors of microtubule dynamics optically control mitosis and cell death

M Borowiak, W Nahaboo, M Reynders, K Nekolla… - Cell, 2015 - cell.com
Small molecules that interfere with microtubule dynamics, such as Taxol and the Vinca
alkaloids, are widely used in cell biology research and as clinical anticancer drugs …

Light-triggered switching of liposome surface charge directs delivery of membrane impermeable payloads in vivo

G Arias-Alpizar, L Kong, RC Vlieg, A Rabe… - Nature …, 2020 - nature.com
Surface charge plays a fundamental role in determining the fate of a nanoparticle, and any
encapsulated contents, in vivo. Herein, we describe, and visualise in real time, light …

Beyond photodynamic therapy: light-activated cancer chemotherapy

F Reeæ# 159; ing, W Szymanski - Current Medicinal Chemistry, 2017 - benthamdirect.com
Background: Cancer chemotherapy is limited by severe side effects due to unspecific
cytotoxic activity of currently used therapeutics. In order to minimize these unwanted effects …

Nuclear targeting with an Auger electron emitter potentiates the action of a widely used antineoplastic drug

S Imstepf, V Pierroz, P Raposinho… - Bioconjugate …, 2015 - ACS Publications
We present the combination of the clinically well-proven chemotherapeutic agent,
Doxorubicin, and 99mTc, an Auger and internal conversion electron emitter, into a dual …

[HTML][HTML] Site-specific antibody masking enables conditional activation with different stimuli

R Lucchi, MC Lucana, M Escobar-Rosales… - New …, 2023 - Elsevier
Antibody therapeutics show great potential to treat a variety of diseases. Often, the dose that
can be safely administered is limited by side effects that arise from the interaction with the …

[HTML][HTML] Synthesis and preliminary anticancer evaluation of photo-responsive prodrugs of hydroxymethylene bisphosphonate alendronate

A Descamps, P Arnoux, C Frochot, F Barbault… - European Journal of …, 2024 - Elsevier
The antitumoral activity of hydroxymethylene bisphosphonates (HMBP) such as alendronate
or zoledronate is hampered by their exceptional bone-binding properties and their short …

Synthesis and Investigations of Building Blocks with Dibenzo[b,f] Oxepine for Use in Photopharmacology

P Tobiasz, F Borys, M Borecka, H Krawczyk - International Journal of …, 2021 - mdpi.com
The synthesis of photoswitchable azo-dibenzo [b, f] oxepine derivatives and microtubule
inhibitors were described. Subsequently, we examined the reaction of methoxy derivative 3 …

Chronic activation of the D156A point mutant of Channelrhodopsin-2 signals apoptotic cell death: the good and the bad

M Perny, L Muri, H Dawson, S Kleinlogel - Cell death & disease, 2016 - nature.com
Abstract Channelrhodopsin-2 (ChR2) has become a celebrated research tool and is
considered a promising potential therapeutic for neurological disorders. While making its …